Summary & Overview
CPT 93452: Left Heart Catheterization with Left Ventriculography
Headline: CPT 93452: Left Heart Catheterization with Left Ventriculography — Key Procedural and Coverage Considerations
Lead: CPT 93452 represents a diagnostic left heart catheterization that includes intraprocedural injections for left ventriculography and associated imaging supervision and interpretation. This procedure is a cornerstone in invasive cardiology for assessing left ventricular structure and function.
What the code represents and its national relevance: CPT 93452 codifies a commonly performed invasive cardiac procedure used to evaluate ventricular function, coronary anatomy adjuncts, and hemodynamics. It matters nationally because it is integral to diagnostic workflows for complex cardiac infections, inflammatory and neoplastic heart conditions, and other indications where direct ventricular imaging informs clinical management.
Key payers covered: The analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Overview of reader takeaways: Readers will find a concise description of the procedure and clinical context, payer coverage scope, typical sites of service, and associated procedural relationships. The publication summarizes common coding relationships and related add-on CPTs that may be billed in conjunction with left heart catheterization, and highlights typical clinical scenarios where the procedure is used.
Scope and limitations: Where specific operational or local policy details are unavailable, the publication notes "Data not available in the input." No clinical recommendations are provided; content focuses on coding, service context, and payer inclusion.
CPT Code Overview
CPT 93452 describes a left heart catheterization procedure that includes intraprocedural injection(s) for left ventriculography along with imaging supervision and interpretation when performed. This code applies to diagnostic and evaluative catheter-based access to the left-sided cardiac chambers with concurrent contrast injection to visualize ventricular function.
Service Type: Cardiology / Cardiac Catheterization
Typical Site of Service: Hospital outpatient (e.g., Outpatient facility, POS 19/22) or Inpatient hospital (POS 21)
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient is admitted to the hospital with signs of acute heart failure and suspected ischemic cardiomyopathy. After initial evaluation including ECG, cardiac biomarkers, and transthoracic echocardiography demonstrating reduced left ventricular function, the cardiology team schedules a left heart catheterization with left ventriculography to define coronary anatomy and assess left ventricular systolic function. The procedure is performed in the cardiac catheterization laboratory in a hospital outpatient setting (POS 19/22) or during an inpatient admission (POS 21). Vascular access is obtained (typically via femoral or radial artery), a left-sided diagnostic catheter is advanced to the left coronary ostium for coronary angiography, and contrast is injected for left ventriculography with imaging supervision and interpretation documented in the procedural report.
Coding Specifications
Modifier 26 is used when only the professional component (physician interpretation and report) is billed separately.
Modifier TC is used when only the technical component (facility, equipment, technologist) is billed.
Modifier 59 is used to indicate a distinct procedural service when another procedure performed on the same day is not typically reported together.
- Associated provider taxonomies:
| Taxonomy Code | Specialty |
|---|---|
246XC2901X | Cardiovascular Invasive Specialist/Technologist |
The taxonomy 246XC2901X represents clinical personnel who perform and assist with invasive cardiovascular procedures in the catheterization laboratory, supporting imaging acquisition and device handling.
Related Diagnoses
-
A39.50— Meningococcal carditis, unspecifiedClinical relevance: Infectious involvement of cardiac structures may prompt diagnostic catheterization and ventriculography when structural dysfunction or hemodynamic compromise is suspected.
-
A39.51— Meningococcal endocarditisClinical relevance: Endocarditis with suspected valvular involvement can lead to hemodynamic instability or embolic risk that may necessitate catheterization for assessment.
-
A39.52— Meningococcal myocarditisClinical relevance: Myocardial inflammation affecting ventricular function can be evaluated with left ventriculography to quantify systolic performance.
-
A52.02— Syphilitic aortitisClinical relevance: Aortitis with possible aortic root or valve involvement may require invasive imaging during cardiac catheterization.
-
A52.03— Syphilitic endocarditisClinical relevance: Valvular infection or dysfunction associated with syphilis can prompt invasive assessment.
-
A52.06— Other syphilitic heart involvementClinical relevance: Other cardiac manifestations of syphilis that affect structure or function may be assessed during left heart catheterization.
-
A54.83— Gonococcal heart infectionClinical relevance: Infectious cardiac disease with suspected structural compromise may lead to invasive diagnostic procedures.
-
A78— Q feverClinical relevance: Q fever can involve endocardium or myocardium; invasive evaluation may be indicated for structural assessment.
-
B33.20— Viral carditis, unspecifiedClinical relevance: Viral inflammation of the heart with ventricular dysfunction can be evaluated with ventriculography during catheterization.
-
B33.21— Viral endocarditisClinical relevance: Viral infection of valves may prompt invasive assessment for hemodynamic impact.
-
B33.22— Viral myocarditisClinical relevance: Myocarditis affecting left ventricular function is a reason for left ventriculography to document ejection fraction.
-
B37.6— Candidal endocarditisClinical relevance: Fungal endocarditis with suspected valvular damage can necessitate catheterization for assessment.
-
B57.0— Acute Chagas' disease with heart involvementClinical relevance: Acute Chagas myocarditis/endocarditis causing ventricular dysfunction may be evaluated invasively.
-
B57.2— Chagas' disease (chronic) with heart involvementClinical relevance: Chronic Chagas cardiomyopathy with left ventricular dysfunction is assessed with ventriculography.
-
C38.0— Malignant neoplasm of heartClinical relevance: Cardiac tumors affecting chamber size or function may be assessed during catheterization.
-
C45.2— Mesothelioma of pericardiumClinical relevance: Pericardial involvement with hemodynamic effects may prompt invasive assessment.
-
D15.1— Benign neoplasm of heartClinical relevance: Benign cardiac masses with functional impact can be evaluated with left ventriculography.
-
D86.0— Sarcoidosis of lungClinical relevance: Systemic sarcoidosis with potential cardiac involvement can lead to invasive assessment of ventricular function.
-
D86.1— Sarcoidosis of lymph nodesClinical relevance: Sarcoidosis with possible cardiac infiltration may prompt ventriculographic evaluation.
-
D86.2— Sarcoidosis of lung with sarcoidosis of lymph nodesClinical relevance: Combined involvement raises suspicion for cardiac sarcoidosis and need for functional assessment.
-
D86.3— Sarcoidosis of skinClinical relevance: Cutaneous sarcoidosis as part of systemic disease may be associated with cardiac involvement requiring evaluation.
-
D86.81— Sarcoid meningitisClinical relevance: Neurologic sarcoidosis as part of systemic disease can be associated with cardiac involvement warranting assessment.
Related CPT Codes
| CPT Code | Description |
|---|---|
93462 | Transeptal/transapical left heart catheterization (as add‑on) |
93566 | Right atrial angiography (add‑on) |
93567 | Supravalvular aortography (add‑on) |
93568 | Pulmonary angiography (add‑on) |
93462 is an add‑on for transeptal or transapical access when those additional left heart access techniques are performed in conjunction with the primary left heart catheterization. 93566, 93567, and 93568 are add‑on angiographic studies that may be performed during the same catheterization session to image the right atrium, supravalvular aorta, or pulmonary circulation respectively. These add‑on codes are commonly reported together with 93452 when the additional angiographic studies are performed during the same procedure; they are not alternatives to 93452 but supplemental codes.
National Reimbursement Benchmarks
National mean commercial rates for CPT 93452 are materially higher than Medicare. The BUCA composite (average commercial) mean of $857.16 exceeds the Medicare mean of $606.52 by $250.64, reflecting higher allowed amounts in the commercial market compared with the Medicare locality-based mean.
Dispersion varies by payer: Blue Cross Blue Shield and BUCA display the widest interquartile ranges (BCBS P75−P25 = $398.67; BUCA P75−P25 = $360.64), indicating greater spread in allowed rates. Aetna and Medicare are among the tightest (Aetna P75−P25 = $182.00; Medicare P75−P25 = $610.50, noting Medicare's P25 is much lower and reflects locality variation), while Cigna and UnitedHealth Group show substantial upper-tail values with P75−P25 of $498.40 and $505.50 respectively. The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.